The study assesses the effectiveness of hyperbaric oxygen therapy in the treatment of inflammatory bowel disease in children.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Hyperbaric Oxygen Therapy
Medical University of Warsaw
Warsaw, Poland
RECRUITINGChange of the ulcerative colitis activity
Change in the disease activity based on the Paediatric Ulcerative Colitis Activity Index (PUCAI) for patients with ulcerative colitis.
Time frame: 40 days
Change of the Crohn's disease activity
Change in the disease activity based on the Pediatric Crohn's Disease Activity Index (PCDAI) for patients with Crohn's disease.
Time frame: 40 days
Number of participants with treatment-related adverse events
Number of participants with treatment-related adverse events and the the severity of these events.
Time frame: 40 days
Concentration of proinflammatory cytokines
Time frame: 40 days
Maintaining remission of the ulcerative colitis
Duration of the clinical remission time (if achieved) assessed according to the Paediatric Ulcerative Colitis Activity Index (PUCAI) for patients with ulcerative colitis.
Time frame: 1 year
Maintaining remission of the Crohn's disease
Duration of the clinical remission time (if achieved) assessed according to the Pediatric Crohn's Disease Activity Index (PCDAI) for patients with Crohn's disease.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.